TOP2A and ovarian cancer: The results revealed that CDK1, CDC20, CCNB1, BUB1B, CCNA2, KIF11, CDCA8, KIF2C, NDC80 and TOP2A were all expressed at higher levels in ovarian cancer tissues than in normal tissues (Fig. 7 and 8).